Neoadjuvant Therapy with Drug Arglabin for Breast Cancer with Expression of H-Ras Oncoproteins

BACKGROUNDS: In breast cancer, blocking of Ras signaling and inhibition of H-Ras is quite promising. H-Ras may become a target for farnesyl transferase inhibitors, and in combination with other immunohistochemical factors it will contribute to the progression of a breast tumor. PURPOSE: The aim of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Adekenov, Sergazy, Zhumakayeva, Ainur, Perminov, Vladimir, Bekmanov, Bakhytzhan, Rakhimov, Kayrolla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033125/
https://www.ncbi.nlm.nih.gov/pubmed/33247707
http://dx.doi.org/10.31557/APJCP.2020.21.11.3441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033125/
https://www.ncbi.nlm.nih.gov/pubmed/33247707
http://dx.doi.org/10.31557/APJCP.2020.21.11.3441

Ejemplares similares